Skip to Main Content

Author Details

Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
1982
482
91
PMIDPaper TitleJournal TitlePublished Year
37611810The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans.Int J Radiat Oncol Biol Phys2024
37751180Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma.Cancer2024
36416855Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg2023
37799466Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis.Front Oncol2023
37478572The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.Oral Oncol2023
37499325Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients.Oral Oncol2023
37498564Individualized risk assessment of distant metastases in oral cavity carcinoma: a validated predictive-score model.J Natl Cancer Inst2023
37045788Incidence and predictive factors of retropharyngeal lymph node metastases in patients with oropharyngeal cancer undergoing multimodality treatment planning imaging.Head Neck2023
36780824The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis.Oral Oncol2023
36912224Are we ready for deintensification in human papillomavirus-positive oropharyngeal carcinomas?Curr Opin Otolaryngol Head Neck Surg2023
36796393Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.Lancet Oncol2023
34792199Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.Int J Cancer2022
35454830An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.Cancers (Basel)2022
35588085Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.Cancer2022
35905781Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary.Radiother Oncol2022
36354715Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers.Curr Oncol2022
36353565Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma.Front Oncol2022
36010888Oligometastatic Head and Neck Cancer: Challenges and Perspectives.Cancers (Basel)2022
35315548Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer.Head Neck2022
35038657Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.Oral Oncol2022
35121396Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.Oral Oncol2022
34971660Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial.Radiother Oncol2022
35305091Unfinished Business in Classifying HPV-Positive Oropharyngeal Carcinoma: Identifying the Bad Apples in a Good Staging Barrel.Oncologist2022
35238880Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.JAMA Otolaryngol Head Neck Surg2022
33002201Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes.Laryngoscope2021
33768007Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma.Front Oncol2021
33600871Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.Radiother Oncol2021
33571626International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma.Int J Radiat Oncol Biol Phys2021
33516790Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems.Radiother Oncol2021
33508706Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.Oral Oncol2021
33507809Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).J Clin Oncol2021
33532634Statistical fundamentals on cancer research for clinicians: Working with your statisticians.Clin Transl Radiat Oncol2021
33862002Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.Lancet Oncol2021
33580567Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.Head Neck2021
33524796Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey.Oral Oncol2021
33856051Importance of Margins, Radiotherapy, and Systemic Therapy in Mucosal Melanoma of the Head and Neck.Laryngoscope2021
34940071Examining the Landscape of Prognostic Factors and Clinical Outcomes for Cancer Control.Curr Oncol2021
34540670Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.Front Oncol2021
34718052Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort.Radiother Oncol2021
34418466Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.Int J Radiat Oncol Biol Phys2021
34062618A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.Cancer2021
34175612Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study.Oral Oncol2021
34010048Assessment Criteria and Clinical Implications of Extranodal Extension in Head and Neck Cancer.Am Soc Clin Oncol Educ Book2021
34261594The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer.Clin Oncol (R Coll Radiol)2021
34359623Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models.Cancers (Basel)2021
33058305Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.Head Neck2021
33057952Comparison of different guidelines for oral cancer.Eur Arch Otorhinolaryngol2021
33264637Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma.Radiother Oncol2021
32861702Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach.Radiother Oncol2021
31568813The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.Int J Radiat Oncol Biol Phys2020
  • 1 - 50 of 482

Recommended Authors

Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 12
Krupal B Patel
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 10
Neil Mundi
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 8
Musaddiq J Awan
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 6
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 12
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 4
Ryan K Orosco
university of california san diego
Career Start Year 2010
Number of shared co-authors 4
Katharine A Price
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 13
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 6
Daniel J Ma
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 15
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 13
Anthony C Nichols
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 38
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 15
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 1
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 9
Barbara Bachtiary
Center for Proton Therapy, Paul Scherrer Institute
Career Start Year 2000
Number of shared co-authors 9
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 14
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 18
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 8
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 16
Coen R N Rasch
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 9
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 11
John M Kane
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 5
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 10
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 12
Wayne M Koch
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 5
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 18
Michael P Hier
Jewish General Hospital, McGill University
Career Start Year 1987
Number of shared co-authors 13
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 4

Collaborators

John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 136
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 136
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 86
Jonathan C Irish
Princess Margaret Cancer Centre
Co-authored papers 79
David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 75
Jay S Wunder
University of Toronto
Co-authored papers 65
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 64
Bayardo Perez-Ordonez
University Health Network
Co-authored papers 37
Ilan Weinreb
University Health Network
Co-authored papers 37
Ralph W Gilbert
Princess Margaret Cancer Centre
Co-authored papers 37
Ali Hosni
Princess Margaret Cancer Center
Co-authored papers 35
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Co-authored papers 33
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Co-authored papers 28
Angela B Y Hui
Stanford University
Co-authored papers 22
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 15
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 14
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 13
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 9
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Co-authored papers 9
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 8
Richard P Hill
Princess Margaret Cancer Centre
Co-authored papers 8
David I Rosenthal
MD Anderson Cancer Center
Co-authored papers 6
Brendan C Dickson
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Co-authored papers 6
Carlo Bastianutto
University of Toronto
Co-authored papers 6
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Susie Su
Zhabei Central Hospital
Co-authored papers 4
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 4
Philippe Lambin
Maastricht University
Co-authored papers 4
Lawson Eng
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Release 1.2